(Q34106426)

English

Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

author name string

Marise B Parent

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sangeeta Master

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shauna Kashlub

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Glen B Baker

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

57-64

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Some effects of monoamine oxidase inhibitors on the metabolism of gamma-aminobutyric acid in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

[Atypical depression: evolution toward a specific pharmacologic and efficacious treatment?]

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Depletion of brain norepinephrine: differential influence on anxiolyic treatment effects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Effects of the antidepressant phenelzine on brain levels of γ-aminobutyric acid (GABA)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Sustained drug-induced elevation of brain GABA in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Oxidation of 2-phenylethylhydrazine by monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Inhibition of monoamine oxidase by substituted hydrazines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Role of gamma-aminobutyric acid in antipanic drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA) on rat exploratory activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

GABAergic influences on plus-maze behaviour in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Cortical magnetic resonance imaging changes in elderly inpatients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Neuroanatomical substrates of depression in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Brain blood flow in anxiety disorders. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single photon emission tomography (SPET).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Involvement of brain trace amines in the behavioural effects of phenelzine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Duration-dependent increase in striatal glutamate following prolonged fluphenazine administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Brain microdialysis of GABA and glutamate: what does it signify?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Amphetamine lowers extracellular GABA concentration in the ventral pallidum.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Extracellular gamma-aminobutyric acid levels in the rat caudate-putamen: monitoring the neuronal and glial contribution by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

The effect of phencyclidine on the basal and high potassium evoked extracellular GABA levels in the striatum of freely-moving rats: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Use of fluorocitrate and fluoroacetate in the study of brain metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

Role of GABA in memory and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900856-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(01)00856-5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34106426&oldid=1539858454"